ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Recombinant Anti-CDCP1 Antibody [Research Grade Biosimilar] - Low endotoxin, Azide free (A323960)

Recombinant human monoclonal antibody to CDCP1 for ELISA, FACS, Functional Assay and In Vivo.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 12-18 business days.
Name
Anti-CDCP1 Antibody [Research Grade Biosimilar] - Low endotoxin, Azide free
Description
Recombinant human monoclonal antibody to CDCP1.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 150 kDa.
Purity
> 90% (by SDS-PAGE and SEC-HPLC).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
CD318, CUB domain-containing protein 1, Membrane glycoprotein gp140, SIMA135, Subtractive immunization M plus HEp3-associated 135 kDa protein, Transmembrane and associated with src kinases, TRASK
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Recombinant Anti-CDCP1 Antibody [Research Grade Biosimilar] - Low endotoxin, Azide free (A323960)? Please let us know so that we can list the citation on this page.

Alternative products to Anti-CDCP1 Antibody [Research Grade Biosimilar] - Low endotoxin, Azide free (A323960)

Proteins predicted to interact with CDCP1

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
94.2% Relevancy Score
90% Relevancy Score
81% Relevancy Score
80.6% Relevancy Score
78.6% Relevancy Score
70.5% Relevancy Score
69.5% Relevancy Score
62.9% Relevancy Score
58.2% Relevancy Score